Hilton Pharma

What Hilton Pharma does

Hilton Pharma is a privately held pharmaceutical products manufacturer headquartered in Karachi, Pakistan, founded in 1976. The company operates at meaningful scale, employing between 1,001 and 5,000 people, which positions it within the mid-tier of Pakistan's domestic pharmaceutical industry. Its corporate website (hiltonpharma.com) is the primary public-facing channel but did not return substantive product or technology content during data collection, limiting visibility into its specific therapeutic portfolio, manufacturing capabilities, and geographic footprint.

The business model is consistent with a domestic-focused pharmaceutical manufacturer: revenue is generated through the production and sale of finished pharmaceutical formulations to distribution intermediaries, retail pharmacies, hospitals, and institutional buyers in Pakistan, with regulatory oversight provided by the Drug Regulatory Authority of Pakistan (DRAP). The company is led by Shahbaz Yasin Malik in the combined role of President and CEO, indicating a concentrated top-executive structure typical of family- or founder-influenced Pakistani pharma firms. No information on export markets, contract manufacturing arrangements, API production, biosimilars, or specialty therapeutic focus was available in the source material.

Nearly five decades of continuous operation suggests an established manufacturing base, DRAP-licensed product portfolio, and entrenched relationships across Pakistan's pharmaceutical distribution network. However, due diligence on Hilton Pharma would require primary research to assess product mix, capacity utilization, geographic exposure (domestic vs. export), R&D pipeline, ownership structure, and financial performance — none of which are publicly disclosed in the materials available for this assessment.

Name

Hilton Pharma

Website

https://hiltonpharma.com

Company type

Private

Founded year

1976

Headcount range

1,001–5,000 employees

Short description

Hilton Pharma is a privately held Pakistani pharmaceutical manufacturer founded in 1976 and headquartered in Karachi, employing 1,001–5,000 people to produce and supply pharmaceutical formulations across domestic and regional markets.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Full-Line Pharmaceutical Wholesalers (HLAIAJAA)

Keywords

• Pharmaceutical manufacturing
• Generic medicines
• Finished dosage forms
• Pharmaceutical products
• Human healthcare products

Headquarters

HQ city

Karachi

HQ country

Pakistan

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D

Core offering

Hilton Pharma is a pharmaceutical products manufacturing company based in Karachi, Pakistan, founded in 1976. The company manufactures pharmaceutical products, operating with a workforce of 1,001-5,000 employees. Specific product lines, therapeutic areas, and detailed manufacturing capabilities are not disclosed in the available source content.

Product overview

No product information available. The source website displayed a verification/loading page without accessible content.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Direct peers

• Getz Pharma: Pakistan-based pharmaceutical manufacturer with a broad branded generics portfolio across multiple therapeutic areas. Directly comparable to Hilton Pharma as a domestic Pakistani manufacturer of similar scale and channel mix.
• Searle Pakistan: Listed Pakistani pharmaceutical manufacturer focused on branded generics and consumer health. Closely comparable to Hilton Pharma in domestic manufacturing footprint, therapeutic breadth, and reliance on Pakistan's retail and institutional channels.
• Highnoon Laboratories: Pakistani pharmaceutical manufacturer with a portfolio spanning branded generics and specialty products. Closely comparable to Hilton Pharma in manufacturing scale, therapeutic mix, and domestic market focus.
• Ferozsons Laboratories: Listed Pakistani pharmaceutical company with branded generics and a hepatitis B vaccine partnership. Comparable to Hilton Pharma as a domestic manufacturer operating in similar therapeutic and channel segments.
• AGP Limited: Pakistani pharmaceutical manufacturer with branded generics and a sizable domestic sales force. Directly comparable to Hilton Pharma in scale, therapeutic breadth, and channel orientation.
• Sami Pharmaceuticals: Pakistan-based pharmaceutical manufacturer producing branded and generic formulations for domestic and export markets. Comparable to Hilton Pharma as a domestic manufacturer of similar scale and product mix.
• The Searle Company: Pakistani pharmaceutical group engaged in manufacturing, marketing, and export of branded generics. Comparable to Hilton Pharma in domestic manufacturing scale, therapeutic breadth, and regional ambitions.

Broad incumbents

• Abbott Pakistan: Local affiliate of a global pharma major manufacturing and marketing a broad portfolio of pharmaceuticals, nutritional, and diagnostic products in Pakistan. A relevant broader incumbent peer competing with Hilton Pharma across primary care and specialty categories.
• GSK Pakistan: Subsidiary of a multinational pharma company with branded prescription and consumer healthcare products in Pakistan. Comparable as a large incumbent competitor with deeper R&D and global pipeline than a domestic manufacturer like Hilton Pharma.
• Sanofi Pakistan: Multinational pharmaceutical company operating in Pakistan across specialty care, vaccines, and consumer health. Directly competes with Hilton Pharma in selected therapeutic areas while bringing global pipeline assets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/hilton_pharma
• Facebookfacebook.com/HiltonPharmaGroupOfficial
• LinkedInlinkedin.com/company/hilton-pharma-limited

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hilton Pharma